{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Compugen Ltd."},"Symbol":{"label":"Symbol","value":"CGEN"},"Address":{"label":"Address","value":"26 HAROKMIM STREET,BUILDING D, AZRIELI CENTER, HOLON, 5885849, Israel"},"Phone":{"label":"Phone","value":"+972 37658585"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Middle East"},"CompanyDescription":{"label":"Company Description","value":"Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its innovative immuno-oncology pipeline consists of four clinical stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets."},"CompanyUrl":{"label":"Company Url","value":"https://www.cgen.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Anat Cohen-Dayag","title":"President, Chief Executive Officer & Director"},{"name":"Eran Ophir","title":"Chief Scientific Officer"},{"name":"Michelle Mahler","title":"Chief Medical Officer"},{"name":"Zurit Levine","title":"Vice President-Technology Innovation"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}